TickerFacts.

Advanced Biomed Inc. (ADVB): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$1.95M
Year ended 2026-06-30
2024-06-30: -$2.13M2025-06-30: -$5.83M2026-06-30: -$1.95M-$1.95M
2024-06-30 Operating Cash Flow (USD) 2026-06-30
Period endedOperating Cash FlowChange YoYSource filing
2026-06-30-$1.95Mn/m2026-10-13, From 2025-07-01
2025-06-30-$5.83Mn/m2026-10-13, From 2024-07-01
2024-06-30-$2.13Mn/a2025-10-08, From 2023-07-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Advanced Biomed Inc. (ADVB)2026-06-30-$1.95Mn/m
YD Bio Ltd (YDES)2025-12-31-$6.60Mn/m
Aclarion, Inc. (ACON)2025-12-31-$7.16Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31-$1.84Mn/m
CapForce Inc. (CFOR)2025-12-31-$1.18Mn/m
First Choice Healthcare Solutions, Inc. (FCHS)2025-12-31-$549.0Kn/m
American Shared Hospital Services (AMS)2025-12-31$3.10Mn/m
Exagen Inc. (XGN)2025-12-31-$13.62Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.27Mn/m

Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗